|
Volumn 37, Issue 1, 2001, Pages 89-92
|
Testing our tests: Surrogate end points versus driving patient management and outcomes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOBUTAMINE;
GLUCOSE;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
TECHNETIUM 99M;
THALLIUM 201;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
ECHOCARDIOGRAPHY;
EDITORIAL;
HUMAN;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SCINTISCANNING;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
AGED;
CORONARY DISEASE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PREDICTIVE VALUE OF TESTS;
SURVIVAL RATE;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 0035162441
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(00)01082-2 Document Type: Editorial |
Times cited : (4)
|
References (24)
|